A Google Doodle is a special, temporary alteration of the logo on Google's homepages. Google honoured Indian-American biochemist and Nobel laureate Har Gobind Khorana, known as the first scientist to chemically synthesise DNA molecules, with a doodle marking his 96th birth anniversary.
Khorana was born in Raipur, which is Kabirwala in present-day Pakistan. He was the youngest of five children.
Cancer Treatment Outcome Predicted by Mutation in Tumor DNA
Higher 'mutational burden' predicts which cancer types will respond to therapies known as checkpoint inhibitors.
Advertisement
‘The Google Doodle honoured Har Gobind Khorana, who won a Nobel Prize in 1968 for his work on genes and nucleotides, which are the basic structural units of DNA.’
Tweet it Now
His father Ganpat Rai Khorana worked as a taxation clerk in the British Indian administration. The Khoranas were the only literate family in the village with nearly 100 people.
Khorana lived in India until 1945 and then moved to England to study for a Ph.D degree at the University of Liverpool, after which he received a Fellowship award from the Indian government.
![Synthetic DNA Molecules Help in Early Disease Diagnosis]( "Synthetic DNA Molecules Help in Early Disease Diagnosis")
Detection of single molecules of biomarkers using aptamers or synthetic DNA molecules help in early diagnosis.
From 1952 to 1960, Khorana served as a faculty at the University of British Columbia, where he began his Nobel Prize winning work in the field of biologically interesting phosphate esters and nucleic acids.
In 1966, he became a naturalized citizen of the US and also received the prestigious National Medal of Science award.
In 1968, he bagged the Nobel Prize for Physiology or Medicine along with Marshall W. Nirenberg and Robert W. Holley for his research that showed how the order of nucleotides in nucleic acids, which carry the genetic code of the cell, control the cell's synthesis of proteins.
Khorana died of natural causes in November 2011 in Massachusetts, aged 89. He is survived by his children Julia and Davel.
Source: IANS
Synthetic DNA Molecules Help in Early Disease Diagnosis
Detection of single molecules of biomarkers using aptamers or synthetic DNA molecules help in early diagnosis.
Advertisement
From 1952 to 1960, Khorana served as a faculty at the University of British Columbia, where he began his Nobel Prize winning work in the field of biologically interesting phosphate esters and nucleic acids.
In 1966, he became a naturalized citizen of the US and also received the prestigious National Medal of Science award.
In 1968, he bagged the Nobel Prize for Physiology or Medicine along with Marshall W. Nirenberg and Robert W. Holley for his research that showed how the order of nucleotides in nucleic acids, which carry the genetic code of the cell, control the cell's synthesis of proteins.
Khorana died of natural causes in November 2011 in Massachusetts, aged 89. He is survived by his children Julia and Davel.
Source: IANS
New DNA Annotation Can Predict Outcomes in Childhood Leukemia
New test developed helps predict how children with Juvenile myelomonocytic leukemia (JMML) respond to treatment immediately with little or no treatment.
Advertisement
 Genetic Change in DNA Associated With Movement DisorderX-linked dystonia parkinsonism is a rare movement disorder that is found to be due to changes in the DNA. | Advertisement
|
Advertisement
Latest General Health News
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.